These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 15886070)

  • 21. Successful treatment of multidrug-resistant Pseudomonas aeruginosa meningitis with intravenous and intrathecal colistin.
    Schina M; Spyridi E; Daoudakis M; Mertzanos E; Korfias S
    Int J Infect Dis; 2006 Mar; 10(2):178-9. PubMed ID: 16263315
    [No Abstract]   [Full Text] [Related]  

  • 22. Cure of multidrug-resistant Acinetobacter baumannii bacteraemia with continuous intravenous infusion of colistin.
    Michalopoulos A; Kasiakou SK; Rosmarakis ES; Falagas ME
    Scand J Infect Dis; 2005; 37(2):142-5. PubMed ID: 15764204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment options for multidrug-resistant nonfermenters.
    Briceño DF; Quinn JP; Villegas MV
    Expert Rev Anti Infect Ther; 2010 Mar; 8(3):303-15. PubMed ID: 20192684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful treatment of meningitis caused by multidrug-resistant Acinetobacter baumannii with intravenous and intrathecal colistin.
    Ho YH; Wang LS; Chao HJ; Chang KC; Su CF
    J Microbiol Immunol Infect; 2007 Dec; 40(6):537-40. PubMed ID: 18087636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
    Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of tigecycline/colistin combination in a pneumonia model caused by extensively drug-resistant Acinetobacter baumannii.
    Mutlu Yilmaz E; Sunbul M; Aksoy A; Yilmaz H; Guney AK; Guvenc T
    Int J Antimicrob Agents; 2012 Oct; 40(4):332-6. PubMed ID: 22831842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.
    Markou N; Markantonis SL; Dimitrakis E; Panidis D; Boutzouka E; Karatzas S; Rafailidis P; Apostolakos H; Baltopoulos G
    Clin Ther; 2008 Jan; 30(1):143-51. PubMed ID: 18343250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety in treatment of ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii with aerosolized colistin in neonates: a preliminary report.
    Nakwan N; Wannaro J; Thongmak T; Pornladnum P; Saksawad R; Nakwan N; Chokephaibulkit K
    Pediatr Pulmonol; 2011 Jan; 46(1):60-6. PubMed ID: 20812247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of nosocomial meningitis due to a multidrug resistant Acinetobacter baumannii with intraventricular colistin.
    Bukhary Z; Mahmood W; Al-Khani A; Al-Abdely HM
    Saudi Med J; 2005 Apr; 26(4):656-8. PubMed ID: 15900379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colistin offers prolonged survival in experimental infection by multidrug-resistant Acinetobacter baumannii: the significance of co-administration of rifampicin.
    Pantopoulou A; Giamarellos-Bourboulis EJ; Raftogannis M; Tsaganos T; Dontas I; Koutoukas P; Baziaka F; Giamarellou H; Perrea D
    Int J Antimicrob Agents; 2007 Jan; 29(1):51-5. PubMed ID: 17189095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infection.
    Cheah SE; Wang J; Nguyen VT; Turnidge JD; Li J; Nation RL
    J Antimicrob Chemother; 2015 Dec; 70(12):3291-7. PubMed ID: 26318190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colistin: an update on the antibiotic of the 21st century.
    Biswas S; Brunel JM; Dubus JC; Reynaud-Gaubert M; Rolain JM
    Expert Rev Anti Infect Ther; 2012 Aug; 10(8):917-34. PubMed ID: 23030331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients.
    Falagas ME; Rafailidis PI; Matthaiou DK; Virtzili S; Nikita D; Michalopoulos A
    Int J Antimicrob Agents; 2008 Nov; 32(5):450-4. PubMed ID: 18768302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii.
    Motaouakkil S; Charra B; Hachimi A; Nejmi H; Benslama A; Elmdaghri N; Belabbes H; Benbachir M
    J Infect; 2006 Oct; 53(4):274-8. PubMed ID: 16442632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intratracheal colistin sulfate for BALB/c mice with early pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
    Chiang SR; Chuang YC; Tang HJ; Chen CC; Chen CH; Lee NY; Chou CH; Ko WC
    Crit Care Med; 2009 Sep; 37(9):2590-5. PubMed ID: 19623044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymyxins: older antibiotics for a new threat.
    Lee SY; Kuti JL; Nicolau DP
    Conn Med; 2006 Jan; 70(1):25-8. PubMed ID: 16479873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.
    Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME
    Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous colistin administration in neonates.
    Jajoo M; Kumar V; Jain M; Kumari S; Manchanda V
    Pediatr Infect Dis J; 2011 Mar; 30(3):218-21. PubMed ID: 21245777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preventing strategy of multidrug-resistant Acinetobacter baumanii susceptible only to colistin in cardiac surgical intensive care units.
    Mastoraki A; Douka E; Kriaras I; Stravopodis G; Saroglou G; Geroulanos S
    Eur J Cardiothorac Surg; 2008 Jun; 33(6):1086-90. PubMed ID: 18339553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa.
    Rice LB
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S100-5. PubMed ID: 16894511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.